An external sensing system in Plasmodium falciparum-infected erythrocytes by Yang Wu et al.
Wu et al. Malar J  (2016) 15:103 
DOI 10.1186/s12936-016-1144-6
RESEARCH
An external sensing system 
in Plasmodium falciparum-infected erythrocytes
Yang Wu1, Laura N. Cruz2, Tadge Szestak1, Gavin Laing1, Gemma R. Molyneux1, Celia R. S. Garcia2 
and Alister G. Craig1*
Abstract 
Background: A number of experiments have previously indicated that Plasmodium falciparum-infected erythro-
cytes (pRBC) were able to sense host environment. The basis of this ability to detect external cues is not known but 
in screening signalling molecules from pRBC using commercial antibodies, a 34 kDa phosphorylated molecule that 
possesses such ability was identified.
Methods: The pRBC were exposed to different culture conditions and proteins were extracted for 1D or 2D gel elec-
trophoresis followed by Western blot. The localization of 34 kDa protein was examined by biochemical fractionation 
followed by Western blot. High-resolution mass spectrometric analysis of immune precipitants was used to identify 
this protein and real-time quantitative reverse transcriptase polymerase chain reaction was used for detecting mRNA 
expression level.
Results: The 34 kDa protein was called PfAB4 has immediate responses (dephosphorylation and rapid turnover) to 
host environmental stimuli such as serum depletion, osmolality change and cytokine addition. PfAB4 is expressed 
constitutively throughout the erythrocytic lifecycle with dominant expression in trophozoites 30 h post-infection. 
Tumour necrosis factor (TNF) treatment induced a transient detectable dephosphorylation of PfAB4 in the ItG strain 
(2 min after addition) and the level of expression and phosphorylation returned to normal within 1–2 h. PfAB4 local-
ized dominantly in pRBC cytoplasm, with a transient shift to the nucleus under TNF stimulation as shown by biochem-
ical fractionation. High-resolution mass spectrometric analysis of immune precipitants of AB4 antibodies revealed 
a 34 kDa PfAB4 component as a mixture of proliferating cellular nuclear antigen-1 (PCNA1) and exported protein-2 
(EXP2), along with a small number of other inconsistently identified peptides. Different parasite strains have differ-
ent PfAB4 expression levels, but no significant association between mRNA and PfAB4 levels was seen, indicating that 
the differences may be at the post-transcriptional, presumably phosphorylation, level. A triple serine phosphorylated 
PCNA1 peptide was identified from the PfAB4 high expression strain only, providing further evidence that the identity 
of PfAB4 is PCNA1 in P. falciparum.
Conclusion: A protein element in the human malaria parasite that responds to external cues, including the pro-
inflammatory cytokine TNF have been discovered. Treatment results in a transient change in phosphorylation status 
of the response element, which also migrates from the parasite cytoplasm to the nucleus. The response element has 
been identified as PfPCNA1. This sensing response could be regulated by a parasite checkpoint system and be analo-
gous to bacterial two-component signal transduction systems.
© 2016 Wu et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Protozoan parasites are capable of withstanding rela-
tively large alterations in their external environments. 
Signalling is perhaps a primal requirement to respond 
to stimuli, the signal transduction systems being able to 
convert an extracellular stimulus into a chemical signal 
that the cell can sense/perceive and recognize, and can 
quickly give responses to the changing environment. 
The malaria parasite has invested in the machinery to 
transduce signals [1] and a number of experiments, such 
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as those carried out by Cohen et al., have indicated that 
Plasmodium falciparum-infected erythrocytes (pRBC) 
may be able to sense host environment, where passive 
transfer of polyclonal sera or purified immune globulin 
from immune adults into P. falciparum-infected indi-
viduals resulted in a significant reduction in blood-stage 
parasitaemia and recovery from clinical symptoms, but 
also boosted gametocyte production [2]. Plasmodium 
falciparum is considered a micro-aerophilic organism 
growing in an environment of limited oxygen content 
0.5–5.0 %. The malaria parasite is under constant oxida-
tive stress caused by exogenous reactive oxidant species 
and reactive nitrogen species (RNS) produced by the host 
immune system and generated by the parasite’s metabo-
lism. Accordingly, parasites have already adapted to cope 
with the external oxidative stress by adapting to the host 
environment through superoxide dismutases and thiore-
doxin-dependent peroxidases, as part of an antioxidant 
defence system of the pRBC [3]. Additionally, revers-
ible phosphorylation has been shown to play an impor-
tant role in parasite invasion [4] and intra-erythrocytic 
growth and development [5], through serine/threonine 
kinases [6–9].
pRBC are known to be able to activate several signal-
ling pathways in the host: for example, MAPK and PI3 
kinases/AKT pathways have been shown to be associ-
ated with malaria infection and pathogenesis via cytoad-
herence [10–12]. It was found that one of NF-kB family 
members REL-1A (P65), almost completely translocated 
into the nucleus within 10 min of pRBC-EC interaction, 
suggesting a direct role for parasite factors in NF-kB 
activation [13]. Src-family signalling mediated ectophos-
phorylation of CD36 on endothelium has also been dem-
onstrated, whereby treating HDMEC with a Src-family 
kinase-selective inhibitor PP1 resulted in a significant 
reduction of pRBC adhesion in a flow-chamber adhe-
sion assay [14]. However, all of these belong to the host 
responses to parasite infection, whereas there are only 
limited numbers of studies about signalling events in 
parasites themselves, despite the existence of an exten-
sive kinase gene family. For example, signal transduc-
tion inside Plasmodium has been shown to be a major 
mechanism to control parasite development [15] with 
regulation in P. falciparum by calcium-dependent protein 
kinase 7 (PfCDPK7) being reported [16]. PfCDPK1 has 
been identified as a Ca2+-dependent effector that plays a 
role in microneme secretion during erythrocyte invasion 
[17]. Mutai and Waitumbi also suggested the existence of 
P. falciparum quorum sensing (the ability to detect con-
ditions of overcrowding), which is more frequently seen 
in small-molecule signalling pathways in bacteria [18], to 
keep the parasite population under check [19]. However, 
the signalling pathways controlling parasite growth and 
defence have not been well studied. Therefore, research 
on signalling molecules from the parasite were under-
taken to understand their pathways and function in 
parasite growth, response and defence against the host 
immune system.
Using a panel of commercial antibodies to several sig-
nalling transduction pathways of different species, only 
one molecule from P. falciparum parasites with the 
appropriate molecular weight was identified. The anti-
body was against human phospho-I-kappaB-α (IκB), an 
important component in the NF kappa B (NFκB) path-
way of mammals. The NFκB pathway is found in almost 
all animal cell types, although not in P. falciparum, 
and is involved in cellular responses to stimuli such as 
cytokines, free radicals, ultraviolet irradiation, oxidized 
LDL, and bacterial or viral antigens. It mediates stress 
and innate immunity and plays a key role in regulating 
the immune response to infection [20, 21].
Activation of NFκB is initiated by the signal-induced 
degradation of IκBα proteins (a negative feedback regu-
lator). IĸBα functions rapidly and is primarily involved 
in determining the temporal profiles of NFκB signalling 
in response to cytokines that serve intercellular com-
munication. Rapid IкBα turnover has been implicated in 
the high basal NFκB activity in WEHI 231 B immature 
IgM+ B cells [22], primarily via activation of the IκB 
kinase.
PfAB4 molecule identified in this investigation has 
several interesting features which could resemble the 
responses of IĸBα/NFκB in mammalian species. How-
ever, there are no NFκB and IκB homologues per se in 
P. falciparum, therefore, the identity of the PfAB4 anti-
body (phosphorylated IκBα antibody)-reacting epitope 
(called PfAB4 in this study) was one of the first questions. 
In this paper, the discovery of a sensing system in P. falci-




Plasmodium falciparum isolates used in this study were 
mainly 3D7 [23], ItG [24] and Dd2 [25], as well as a 
number of patient isolates PO69, PCM-7, BC12, BC31, 
and GL-6 recently characterized in our laboratory [26]. 
Parasites were cultured in  vitro in group O+ human 
erythrocytes using previously described conditions [27, 
28]. To minimize the effect of antigenic switching in 
culture, a batch of stabilates was prepared from a post-
selection culture and used for no more than three weeks. 
Mycoplasma contamination of the parasite culture was 
checked (Universal mycoplasma detecting kit, ATCC, 
UK). pRBC were regularly synchronized by 5 % sorbitol 
treatment or Plasmion-gel flotation.
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Sample preparation from infected erythrocytes 
and immunoblotting
To study the PfAB4 expression profile in the parasites, 
saponin was added to the parasite culture to a final con-
centration of 0.05 % and kept on ice for 8 min to lyse the 
erythrocytes. Following centrifugation at 5000×g at 4 °C 
for 10  min, erythrocyte ghosts were removed and the 
free parasite pellets were washed twice using RPMI 1640 
without serum. The pellet was dissolved in SDS sample 
buffer (final: 3  % [w/v] SDS, 62  mM Tris–HCl pH 6.8, 
15 % [v/v] glycerol) containing 5 % ß-mercaptoethanol), 
vortexed and concentrated for 5  min at 13,000 RPM to 
remove any insoluble material, and this was subjected 
to gel electrophoresis (used as total lysate). This part of 
pRBC was also further extracted by the fractionation 
method described by Voss et al. [29] with modifications. 
Briefly, free parasite pellets were disrupted with ice-cold 
lysis buffer (20  mM Hepes, pH 7.8, 10  mM KCl, 1  mM 
EDTA, 1 mM DTT, 1 mM PMSF, 0.65 % Nonidet P-40) 
and incubated for 5 min on ice. Nuclei were pelleted at 
2500×g for 5  min, the supernatants were used as para-
site cytosol. The nuclear pellet was washed twice in lysis 
buffer, then re-suspended in 2× pellet volume of nuclear 
extraction buffer (20  mM Hepes, pH 7.8, 800  mM KCl, 
1 mM EDTA, 1 mM EGTA, 1 mM DTT) and put on ice 
for 30 min with vigorous shaking every 5 min. The extract 
was cleared by centrifugation at 13,000×g for 30  min. 
The supernatant was used as the parasite nuclear frac-
tion. The insoluble pellet was further washed twice with 
nuclear extraction buffer, pelleted and used as parasite 
insoluble fraction. The protein quantity was controlled 
by using starting material with equal amounts of cul-
ture containing the same parasitaemia and haematocrit. 
Cross-contamination of the nuclear fraction with other 
fractions was investigated using a number of markers, for 
example, histone-nuclear localization and localization of 
other molecules, e.g., HSP90 and PGK should not be in 
nuclear fraction. All of these fractions were diluted with 
2× SDS gel sample buffer. After boiling for 5 min, insolu-
ble material was removed by centrifugation for 5 min at 
13,000×g and the supernatants were run on Thermo Sci-
entific Precise™ precast polyacrylamide gels for protein 
electrophoresis using Tris-HEPES running buffer. These 
fractions were also precipitated by acetone-methanol 
method [30] and were subjected to two-dimensional (2D) 
electrophoresis performed as described previously [31]. 
Briefly, the lysate was solubilized in 2-DE rehydration 
buffer [8 M urea, 2 M thiourea, 2 % CHAPS, 65 mM dith-
iothreitol (DTT), and 0.5 % ampholyte pH 4–7 or 3–10]. 
The sample was vortexed and sonicated on ice ten times 
for 5 s followed by centrifugation at 15,000×g for 10 min. 
The supernatant was subjected to 2-DE and the isoelec-
tric focusing (IEF) by running on precast Amersham 
11 cm pH 3–10 immobiline Drystrip gels using IPG phor 
IEF Unit (Amersham). The narrow pH precast IPG-strips 
of pH 3.9–4.9 were from GENETIX. The running pro-
gramme consists of 10 h for 30 V, 40 min for 200 V, 1 h 
for 500 V, 4 h for 2000 V and finally 8 h for 8000 V. The 
voltage was increased gradually until a total of 80,000 
vh was reached. The focused strips were equilibrated in 
10  ml equilibration solution (50  mM Tris–HCl, pH 6.8, 
6  M urea, 30  % glycerol, 2  % SDS) with reducing agent 
of 1  % DTT for 10  min, and 10  ml equilibration solu-
tion with 4.5  % iodoacetamide for another 10  min. The 
strips were then briefly washed twice with 1× SDS gel 
running buffer and loaded on 10 or 12.5  % SDS-PAGE 
gels for second dimension separation. The gels were run 
at constant current 40 mA in a Laemmli’s buffer system 
[32] until the dye front reached the bottom of the gel. For 
Western blot analysis, the gel-separated proteins were 
transferred electrophoretically to nitrocellulose using 
glycine-tris-methanol buffer. The nitrocellulose mem-
branes were blocked by 1-hour incubation in 5  % skim 
milk in TST buffer (0.01 M Tris pH 8.5/0.15 M sodium 
chloride/0.1  % Tween 20) and washed with TST buffer 
briefly, then probed with different primary antibodies: 
anti-phospho-IκB-α (Cell signalling); anti-EXP2 mAb 
7.7 (kindly provided by Brendan S Crabb); Anti-HSP90α 
and HSP90β (Cell signalling); Anti-GAPDH (Enzo); Anti-
calcineurin (Abgent); Anti-PGK1/2 (Santa Cruz). All pri-
mary antibodies were diluted in Calbiochem Signal Boost 
immunoreaction enhancer solution 1. Goat anti-rabbit or 
anti-mouse (as appropriate) IgG (H + L) horseradish per-
oxidase conjugate (Nordic, 1:2000) was used in enhancer 
solution 2 to localize antibody-antigen complexes and 
visualized with Pierce chemiluminescent (ECL2) systems 
(GE Healthcare).
RNA extraction and real‑time quantitative reverse 
transcriptase polymerase chain reaction (qRT‑PCR)
A TRIzolR Plus RNA Purification Kit (Life Technolo-
gies, UK) was used to extract total RNA from the parasite 
strains using late ring stages at 10 % parasitaemia. RNAs 
were treated with DNase using a Sigma AMPD1-kit at 
room temperature for 15  min, then adding stop solu-
tion and heating at 70  °C for 10  min. Tetro cDNA syn-
thesis kit (Bioline) was used to generate cDNA according 
to manufacturer’s instructions with Oligo-(dt)18 primer. 
q-PCR was carried out using Brilliant III Ultra-Fast SYBR 
Green QPCR Master Mix (Agilent Technologies). Stand-
ard curves were generated for each primer set by per-
forming ten-fold serial dilutions of cDNA to produce five 
different concentrations of starting material. No-RT and 
DEPC-H2O reactions were carried out as negative con-
trols. Details of primers are listed in Table 1. All reactions 
were performed in triplicate. PCR was carried out in an 
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ABI Prism 7000 (Life Technologies). PCR cycling condi-
tions were 95 °C for 3 min, followed by 40 cycles of 95 °C, 
10 s/60  °C, 10 s and a final cycle of 95  °C, 1 min, 55  °C 
for 30 s, 95 °C for 30 s. Adenylosuccinate lyase (ASL) and 
seryl tRNA synthetase (STS) were used as internal con-
trol genes [33]. Relative quantitation was calculated using 
the comparative Ct method (ΔΔCt; Applied Biosystems 
Reference Manual, User Bulletin). Ct values for tran-
scripts of both the reference gene and specific genes were 
below 30 in all samples. Traditional RT-PCR was also 
carried out using generated cDNA as template with PF-
gene-specific primers and amplification products were 
ligated directly into the TA cloning vector, pCRI1 (Invit-
rogen) and sequenced to confirm the products.
Immunoprecipitation (IP) and co‑IP using AB4 antibody 
with Dynabeads®
This is a powerful technique to specifically pull down 
molecules reacting directly with antibodies (IP) and 
to indirectly capture proteins that are bound to a spe-
cific target protein (co-IP). 3D7-infected and unin-
fected erythrocytes (used as control) were disrupted by 
saponin lysis at 4  °C and washed with RPMI medium 
without serum. The parasite pellet was then disrupted 
with IP lysis buffer (50  mM Tris–HCl pH 7.4/150  mM 
NaCl/0.5 % NP-40/1.5 mM MgCl2) by vortexing and cen-
trifuged at 13,000×g for 20  min at 4  °C. Supernatants 
were cleaned using pre-immune rabbit sera to remove 
any non-specific reaction and then incubated with pri-
mary antibody against PfAB4 diluted 1:200 for overnight 
under gentle rotation (15 rpm) at 4 °C. Dynabeads® pro-
tein A or G (Invitrogen) washed three times in cell lysis 
NP-40 buffer were added into the lysate-antibody mix-
ture and incubated at room temperature for 2  h with 
gentle rotation. Beads containing antibody-antigen com-
plexes were washed three times in NP-40 buffer using 
magnetic isolation and reacted proteins were eluted from 
beads by adding 2D gel-electrophoresis buffer, vortexed, 
centrifuged and subjected to 2D gel electrophoresis.
Protein in‑gel digestion, phosphopeptide enrichment, 
nanoflow LC/MS/MS analysis and database searching
Spot picking of interesting proteins in 2D gels was guided 
by immunoblot images on duplicate gels. Immunopre-
cipitated samples were stained with Coomassie blue and 
the most abundant spots were picked. In-gel digestion 
was performed as described below: the excised protein 
spot was put into an Eppendorf Ultra-Pure 1.5  ml cen-
trifuge tube. The band was then cut into 1-cubic mm 
cubes and rinsed twice in 200 µl MilliQ water for 15 min. 
The gel slices were dehydrated by the addition of 100 µl 
of 50  % (v/v) acetonitrile/water and incubated at room 
temperature for 10 min. One-hundred µl of ammonium 
bicarbonate (50  mM) was then added to each sample 
and incubated again at room temperature for 10  min. 
These last two steps were repeated. After removal of the 
ammonium bicarbonate, 10 µl of sequence grade trypsin 
(Promega Southampton, UK) (10  µg  ml−1 in 50  mM 
ammonium bicarbonate) was then added to the gel frag-
ments and incubated at 37 °C for 15 h (overnight), after 
which the supernatant was removed and kept. Twenty 
µl of 70  % acetonitrile (v/v in water) was added to the 
gel and incubated for 10 min at room temperature. The 
supernatant was then removed and pooled with the pre-
vious supernatant. The combined supernatant was dried 
in a speed-vac, re-suspended in 12 µl of 0.1 % formic acid.
The trypsin-digested peptide sample or phospho-
peptides, enriched by Magnetic Titanium Dioxide 
Phosphopeptide Enrichment kit (Pierce) according to 
manufacturer’s instructions, was centrifuged at 13,000×g 
for 15 min to remove any insoluble material. The super-
natant was placed in a new tube and diluted using 0.1 % 
(v/v) formic acid according to loading requirements. For 
LC-MSMS analysis: peptides were initially separated by 
reverse-phase chromatography using a DIONEX Ulti-
Mate™ 3000LC chromatography system. For MS pro-
teomics, 10  µl of peptides were injected onto a C18 
reverse-phase column [2  µm particle size (100), 75  µm 
diameter × 150 mm long] at nanoflow rate (0.3 µl min−1) 
and separated over linear chromatographic gradients. 
The gradients employed for chromatographic separa-
tion were composed of buffer A (2.5 % acetonitrile: 0.1 % 
formic acid) and buffer B (90 % acetonitrile: 0.1 % formic 
acid). For in-gel proteolysis we employed a 60-min linear 
chromatographic gradient. Following chromatographic 
separation, MS analysis was performed on an LTQ Orbit-
rap Velos mass spectrometer using Xcalibur (version 2.1) 
software (Thermo Scientific, UK). Ions were scanned 
between 350–2000  m/z in positive polarity mode. The 
ion-trap operated with CID MS/MS (with wide band 
activation) on the 20 most intense ions. Dynamic exclu-
sion was enabled to avoid repeatedly selecting intense 
ions for fragmentation and this was set at 500 with an 
exclusion duration of 20.0  s. Charge states of 1 were 
rejected. The minimum MS signal threshold was set at 
500 counts and the MS/MS default charge state was 2 
with a 1.2 m/z isolation width, normalized CID at 35 V 
and an activation time of 10 min. The resulting MS/MS 
spectra were submitted to Proteome Discoverer (Thermo 
Scientific, UK) version 1.2. Searching was against NCBI P. 
falciparum and human databases separately and was per-
formed using fixed carbamidomethyl and variable phos-
phorylation modifications. Peptide tolerance was set at 
0.5 Da, MS/MS tolerance was set at 0.1 Da. Phosphoryl-
ated protein identities were considered significant if the 
protein score was over the 95 % confidence limit and at 
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least one phosphorylated site was unambiguously iden-
tified when a phosphorylated residue existed (matched) 
y- or b-ions in the peak lists of the fragment ions [provid-
ing evidence of observed neutral loss of H3PO4 from the 
precursor or identified intact phosphorylated residues of 
serine (pS), threonine (pT) and tyrosine (pY)]. If the pro-
tein score reached a significant level but the ion score of 
phosphorylated peptide was under the 95  % confidence 
limit, these were referred to as potential-phosphorylated 
proteins.
Results
Using ten commercial antibodies to five different signal-
ling transduction pathways, only one positive molecule 
from P. falciparum parasites was identified with an anti-
mammalian phospho-IĸBα antibody, with a molecular 
weight (34  kDa) (Additional file  1). This molecule was 
named PfAB4 and further characterization of PfAB4 
in several P. falciparum laboratory parasite lines was 
undertaken.
According to PlasmoDB, there is no IκB and other 
components of the NFκB pathway in Plasmodium para-
sites. By immune blot using this antibody, we found that 
PfAB4 is a 34 kDa protein expressed at the asexual stage 
of P. falciparum, the expression peak starts at 30 h after 
invasion and lasts to late schizont stages (up to 44 h); at 
the early ring stage the expression level was low (Fig. 1a). 
Calf intestinal alkaline phosphatase (CIP) treatment of 
pRBC lysates from several parasite strains decreased their 
expression of the PfAB4 epitope, indicating that PfAB4 is 
a phosphorylated protein (Fig. 1b). There is also a phos-
phorylated 90 kDa protein reacting with AB4 antibodies 
but lacking stimulation responses, therefore work in this 
paper mainly focused on the 34 kDa PfAB4 protein.
The second feature is the inducible nature of PfAB4 
epitope. This was seen as a rapid turnover and early 
(immediate) response to several stimuli such as osmolal-
ity change, serum depletion/addition and cytokine stimu-
lation. This was a reversible process which is recovered 
within several hours. For example, TNF induced a loss 
of the PfAB4 signal, presumably due to dephosphoryla-
tion/degradation, in several parasite strains (Fig. 2). This 
phenomenon was detectable after 2  min of treatment 
with TNF, while at 60-min incubation the level of this 
epitope was almost back to the original (0  min) signal. 
The response to osmolality is shown in Additional file 2.
The third feature is that different parasite strains have 
different expression levels of the PfAB4 epitope, with 
Fig. 1 Synchronized stage specific ItG parasite lysates at 14, 24, 36 and 46 h after parasite invasion were analysed by Western blot using AB4 
antibodies. PfAB4 expressed throughout parasite lifecycle with expression peak between 28 and 32 h. A 90 kDa protein also reacted with AB4 anti-
bodies. The lower part is the Coomassie blue stained gel image used as loading control (a). Panel b shows parasite strains with CIP in vitro treatment, 
which attenuated the signal indicating the phosphorylation state of PfAB4 proteins
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the levels ranging from high expression to almost absent 
expression (Fig.  3). To confirm that this profile is not 
caused by the variation in stage-specific expression, the 
expression levels of PfAB4 in both high expression and 
low expression parasite strains were measured at time 
points throughout intra-erythrocyte development cycle 
(IDC). The strains of Dd2, BC12 and PCM7 showed con-
sistently low expression at all stages, while ItG, 3D7 and 
A4 demonstrated high PfAB4 expression during the IDC. 
Biochemical fractionation showed that the PfAB4 protein 
in low expression parasite strains, such as Dd2, was only 
detected in the parasite cytosol and no changes were seen 
during IDC development (Additional file 3).
To understand if this difference was at the transcrip-
tional level conventional RT-PCR was carried out for 
the strains with known PfAB4 expression level, but the 
results were inconsistent, therefore, qRT-PCR was car-
ried out to measure the transcript abundance of the 
candidate genes (based on preliminary MS data) from 
different parasite strains with known PfAB4 epitope lev-
els. Three independent RT-qPCR experiments were car-
ried out for six parasite strains and five target genes, all 
results were normalized using internal control and repre-
sented as fold change. The most abundant transcript was 
EXP2, and the least abundant was PCNA2. All strains 
showed variable patterns of transcription of the genes 
being tested, but these were not co-incident with known 
protein levels for PCNA1 and EXP2 (Fig.  4). PCNA1 
and EXP2 from both Dd2 and ItG strains (low and high 
PfAB4 expressers, respectively) have been cloned and 
there were no sequence differences in pcna1 between the 
two strains, although there was a deletion mutation dif-
ference in exp2 between Dd2 and ItG strains.
To view better the expression profiles of PfAB4 under 
TNF stimulation in terms of localization, a combined 
method of saponin lysis and detergent nuclear extrac-
tion was used to separate ItG proteins into pRBC 
ghost, parasite cytosol, nuclear, and insoluble fractions. 
Fig. 2 ItG parasites at mid-trophozoite stage were exposed to TNF (1 ng ml−1) treatment for 2, 5, 15, 30, 60, 120 and 180 min. PBS mock treatment 
was performed as a control. The expression of PfAB4 from total cell lysates was determined by Western blot using AB4 antibodies (upper panel). The 
middle panel shows the quantification of PfAB4 level from three independent experiments by scanning autoradiographs. The lower panel shows a 
Coomassie blue stained image as a loading control
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These four fractions were then subjected to either 
1D SDS-PAGE or 2D gel electrophoresis followed by 
immune-blot using the AB4 antibody. As indicated by 
fractionation, 1D SDS-PAGE and immuno-blotting 
(Fig.  5), PfAB4 is localized both in parasite cytoplasm 
and nucleus. Interestingly, this epitope was able to shift 
between the cell compartments under TNF treatment 
such that for 10–30  min it migrated from cytosol and 
insoluble fractions to the nucleus. At 60  min it was 
seen to accumulate back in the cytosol and insoluble 
fractions. No PfAB4 was detected in the pRBC ghost 
fraction.
Fig. 3 Different parasite strains have different expression levels of PfAB4. The total protein lysates were extracted from ten well-synchronized para-
site strains and analysed for PfAB4 expression level. Dd2, BC12 and PCM7 were repeatedly identified as low expression strains. The lower panel shows 
the Coomasie blue stained image used as a loading control
Fig. 4 RT-qPCR analysis of selected parasite strains for transcript levels of five candidate genes. Three independent qPCR runs were analysed using 
the 2−ΔΔCT method. Data are presented as fold changes against an internal reference gene ASL. The results of Student’s t tests are indicated as  
*P < 0.05; t tests compared the same gene among different strains
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In response to TNF stimulation, PfAB4 molecules not 
only shifted from one compartment to another, but they 
also changed their isoelectric point (PI). To further ana-
lyse these changes, 2D gel strips with a narrow pH range 
of 3.9–4.9 were used to separate PfAB4 isoforms at sev-
eral time points after TNF treatment. Shown in Western 
blots in Fig. 6, PfAB4 isoform shifting in the nucleus was 
from pH 4.9–4.5, moving from basic to acidic direction, 
while in the cytosol, the PI of PfAB4 isoform showed 
minor shifts within the range pH 4.5–4.9, from acidic to 
basic direction (Fig. 6).
One-hundred and 200 µM calpeptin (a calpain inhibi-
tor) treatment 1 h before TNF activation caused a block 
in the degradation of PfAB4 after stimulation with TNF 
(Fig.  7), suggesting that changes in expression of PfAB4 
might be the result of a ubiquitin-independent pathway 
and subsequent degradation by a proteasome complex, 
as previously suggested in other systems by inhibition 
experiments with peptide aldehyde inhibitors of the pro-
teasome, such as calpain inhibitor I [34, 35]. Gambogic 
acid is an important anti-cancer drug candidate, a natu-
ral product inhibitor of HSP90, which inhibits heat shock 
protein 90 and down-regulates TNF/NFκB. It has been 
shown that Gambogic acid physically binds to HSP90, 
inhibiting its ATPase activity and leads to degradation 
of HSP90 client proteins (i.e., Akt, IKK) in HeLa cells 
[36]. In this study, overnight pre-treatment with Gam-
bogic acid (0.5, 1.0 and 1.5  µM) not only inhibited the 
Fig. 5 ItG pRBC were treated with TNF (1 ng ml−1), at the given a time points, followed by cell fractionation using combined methods of saponin 
lysis and detergent extraction. PfAB4 and other candidates’ expression and localization were revealed by Western blot. PfAB4 is localized in parasite 
cytoplasm, nuclear and insoluble fractions. In response to TNF treatment there was a transient shift from cytosol and insoluble compartments to the 
nucleus within 20–30 min. PGK and calcinurin also showed responsiveness to TNF treatment
Fig. 6 Proteins from cytoplasmic and nuclear fractions of ItG pRBC before or after TNF (1 ng ml−1) treatment at the four time points were subjected 
to 2D gel electrophoresis using narrow pH (3.9–4.9) immobiline Drystrips. PfAB4 expression was revealed by Western blot, showing different pat-
terns of migration in the nucleus and cytoplasm over time
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expression of 90  kDa AB4-associated protein, but also 
abrogated the effects of TNF on 34  kDa PfAB4 expres-
sion (Fig.  7) suggesting that AB4 antibody recognized 
90 kDa protein could be a member of HSP90 family and 
that 34 kDa PfAB4 may be associated with HSP90.
There were a number of proteins with sizes around 
34 kDa as seen by staining and immunoblots with differ-
ent antibodies, and intensive methods have been used to 
biochemically separate PfAB4 protein using, for example, 
different gel concentrations, buffer systems and gel types. 
The best and the most reproducible technique was with 
2D electrophoresis separating immune precipitants from 
IP/Co-IP by AB4 antibodies. This allowed the specific 
separation of the target proteins and their associates. The 
34 kDa reaction spot contains in very close proximity or 
overlapping, a mixture of PCNA1 and EXP2 along with 
a small number of other inconsistently identified pep-
tides. A 90  kDa protein was also immuno-precipitated/
co-immunoprecipitated with IDs of HSP86 and HSP70 
(Table 2). 
To confirm the phosphorylation states of the target 
protein and to identify the phosphorylated peptides in 
target proteins, a Titanium Dioxide Phosphopeptide 
Enrichment kit (Pierce) was used to pull down the phos-
phorylated peptides after 1D SDS-PAGE separation and 
trypsin in-gel digestion, from both low and high PfAB4 
expression parasite strains, Dd2 and ItG. The result-
ing trypsinized peptides were subsequently subjected to 
Orbitrap MS analysis, with the results shown in Table 3. 
The phosphorylated peptides of PCNA1 were only found 
in ItG and not Dd2, and there were no EXP2 peptides. 
Therefore the Plasmodium protein recognized by anti-
body to human phospho-IκB-α antibody (AB4) is likely 
to be PfPCNA1. These experiments enabled us to identify 
triple phosphorylation sites in the PfAB4 epitope at ser-
ine 87, serine 91 and serine 92 in PCNA1 (Fig. 8).
Discussion
The intention of this work was to look for parasite sig-
nalling molecules and understand how malaria parasites 
might sense the host environment. To exist in a wide 
range of environmental niches, organisms must sense 
and respond to a variety of external signals.
A primary means by which external sensing occurs in 
bacteria is through two-component signal transduction 
Table 1 Primer sequences for qRT-PCR analysis
Name Primer sequences
PCNA1 Forward: 5′ AGTAGGTGATGCTGAAGTAGC 3′
Reverse: 5′ CCTAAGACAACGACATCTGCT 3′
PCNA2 Forward: 5′ AGGTGTGATAAAAATTGCGTTT 3′
Reverse: 5′ TCGTCAGCACTTGATTGTTC 3′
EXP2 Forward: 5′ AGATGGTCACGTATGTGGTG 3′
Reverse: 5′TGGTTTGGATTCTACGGCAT 3′
HSP86family Forward: 5′ ACCAAGAAGAGGAGAAGTTGG 3′
Reverse: 5′ GCTCTTTGTTCTTCTGCACT 3′
ANP32 Forward: 5′ ACAGACCTTAGAAAATATCCCATCA 3′
Reverse: 5′ TGGTTTCCACCTATTTCAAGGG 3′
Fig. 7 Treatment with different inhibitors, Calpeptin and Gambogoc Acid. a ItG early trophozoite stage pRBC were treated with/without calpeptin, 
a calpain inhibitor for 1 h before TNF stimulation, and the expression of PfAB4 and a 90 kDa protein reacting with AB4 antibodies measured. The 
100 µM calpeptin treatment caused a block of PfAB4 degradation. b ItG early trophozoite stage pRBC were treated with/without Gambogic acid 
(Gam), a HSP90 inhibitor overnight before TNF stimulation. The expression of PfAB4 and a 90 kDa protein reacting with AB4 antibodies was meas-
ured. Gam 0.5, 1.0 and 1.5 µM inhibited the 90 kDa protein expression and reduced the effect on PfAB4 caused by TNF
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pathways, typically composed of a sensor histidine kinase 
that receives the input stimuli and then phosphorylates 
a response regulator that effects an appropriate change 
in cellular physiology. The sensing system described 
in this paper could be part of a two-component signal 
transduction pathway in P. falciparum, which would be 
the first time such a system has been recognized and 
reported. The results indicate that PCNA1 is most likely 
a component of this sensing system. PCNA1 is an aux-
iliary protein of DNA polymerase-delta, forms a trimer 
ring around a DNA double-helix and is a member of the 
DNA sliding clamp family [37]. It is absent or present in 
very low amounts in normal non-dividing cells and tis-
sues, but synthesizes in variable amounts by proliferating 
cells [38, 39].
Phosphorylation/dephosphorylation, ubiquitination, 
sumoylation, and acetylation have all been described for 
nuclear PCNA and offer a range of options to modulate 
PCNA activities [40]. Post-translational modification of 
cytosolic PCNA has been assumed as a key factor in neu-
trophil survival. Neutrophils express high levels of PCNA 
localized exclusively in cytosol, which is ubiquitinated 
and degraded via the proteasome during apoptosis. Fur-
thermore, PCNA nuclear to cytoplasmic delocalization 
at the end of granulocyte differentiation has also been 
demonstrated [41, 42]. These post-translational modifica-
tions of PCNA may be crucial in influencing the cellular 
choice between different pathways, such as the cell cycle 
checkpoint, DNA repair or apoptosis in order to main-
tain genomic stability. A recent study has shown that 
both Pf-PCNA1 and Pf-PCNA2 participate in an active 
DNA-damage-response pathway with significant accu-
mulation in the parasite upon DNA damage induction, 
but Pf-PCNA-mediated regulation was not at the level of 
transcription, but presumably at the protein stability level 
[43]. It has been suggested by this study that one feature 
of regulation is via post-translational modification, and 
that phosphorylation/dephosphorylation controls some 
functions of Pf-PCNA1.
Tumour necrosis factor (TNF) is a pro-inflammatory 
cytokine that plays a critical role in diverse cellular events, 
including cell proliferation, differentiation, and apoptosis. 
Following stimuli by pro-inflammatory cytokines such 
Table 2 Mass spectrometry identifications of AB4 immno-
precipitated material
Accession No. Description MW PI Score
The low molecular weight 34kDa PF-proteins from IP with AB4 antibody
 gi3021540 Exported protein 2 32.9 4.87 455
 gi124513948 Proliferating cell nuclear antigen 1 30.9 4.78 167
 gi160537 Surface protein 27.6 5.12 148
 gi111034851 L-lactate dehydrogenase 34.0 7.55 143
 gi296005038 14-3-3 protein 30.2 4.92 140
 gi124512500 DNA/RNA-binding protein α 27.2 10.58 96
 gi124512686 Proteasome beta-subunit 30.9 6.44 80
 gi124806227 Proliferating cell nuclear antigen 2 30.1 4.68 46
The high molecular weight 90kDa PF-proteins from IP with AB4 antibody
 gi124506906 Heat shock protein 70 72.3 5.31 339.91
 gi124506155 Myo-inositol 1-phosphate synthase, 
putative
69.1 7.4 119.2
 gi124511730 Heat shock protein 86 86.1 5.01 109.85
 gi124512406 Heat shock 70 kDa protein homo-
logue
71.5 6.09 62.36
 gi124513604 Kelch protein, putative 83.6 5.67 164.86
 gi124512982 Vacuolar ATP synthase, catalytic 
subunit a
68.6 4.98 117.28
 gi258597535 Chaperonin, cpn60 81.4 5.11 42.84
 gi124802912 Erythrocyte membrane protein, 
putative
80.2 4.98 113.77
Table 3 Mass spectrometry identifications from phospho-peptide enrichment
Dd2 before enrichment Dd2 after enrichment ItG before enrichment ItG after enrichment
34 kDa/no treatment Heat shock 70 kDa 187
78 kDa glucose-regulated 
protein
Elongation factor 1-alpha mero-
zoite surface protein P12
Putative E3 ubiquitin-protein 
ligase protein
Heat shock 70 kDa protein Proliferating cell nuclear 
antigen






Merozoite surface protein P12
Dynein heavy chain-like protein
Acidic leucine-rich nuclear 
phosphoprotein 32-related 
40S ribosomal protein S3a








70 kDa Knob-associated histidine-rich 
protein
Reticulocyte-binding protein 3
Dynein heavy chain-like protein
Reticulocyte-binding protein 2
MATH and LRR domain-contain-
ing protein




101 kDa malaria antigen
Probable cathepsin C
Heat shock 70 kDa protein
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as TNF and interleukin-1, IkBs are phosphorylated by 
IkB kinase (IKK) in mammalian species resulting in their 
rapid, proteasome-dependent degradation [44, 45]. IkBs 
are regulatory proteins that inhibit NFkB by complexing 
with and trapping it in the cytoplasm. They are involved in 
events including cell adhesion, immune and pro-inflam-
matory responses, apoptosis, differentiation, and growth. 
Although this machinery is not thought to exist in Plas-
modium parasites, an analogous system may have evolved 
to detect this important host protein. Signal transduction 
regulation inside Plasmodium has been shown as a major 
mechanism to control parasite development [15]. In the 
mammalian host, studies have shown that TNF induces 
extensive alterations in host microvascular endothelium, 
including morphological re-organization [46], release of 
membrane microparticles [47], production of other pro-
inflammatory cytokines, up-regulation of receptors and 
apoptosis [48, 49]. Interestingly, inhibitors of TNF pro-
duction reduced infected erythrocyte cytoadherence [50, 
51]. However, TNF signalling in the Plasmodium parasite 
itself has not been previously reported, therefore, under-
standing the mechanisms of sensing TNF stimulation 
seen in this study could improve the molecular descrip-
tion of how Plasmodium adapts to its host environment.
In a parallel study looking for TNF effects on para-
site calcium-dependent signalling, the work showed the 
ability of the parasite to increase intracellular calcium 
concentration after exposure to TNF, thus corroborating 
the hypothesis of an external sensing system allowing the 
parasite to  sense the environment (Cruz et  al., unpub-
lished data). This behaviour is also linked to the parasite 
synchronicity to host circadian rhythms [52] being pre-
viously shown that the parasite cell cycle can be modu-
lated by external signals such as melatonin and products 
of tryptophan catabolism, leading to intracellular calcium 
increase thought a PLC-IP3 mechanism [53–55]. Plasmo-
dium is also able to sense external ATP through rise in 
cytosolic calcium [15, 56]. Moreover, evidence has also 
been provided for K−/Ca2+ signalling mechanisms in P. 
falciparum [57].
The pRBC ghosts contain haemoglobin-depleted eryth-
rocyte material that has lost most of its internal proteins, 
therefore, this fraction represents an enriched erythrocyte 
membrane compartment containing molecules attached/
associated with the membrane. Parasite-encoded mem-
brane proteins translocated to the surface of infected 
erythrocytes or in specialized vesicles underneath (Mau-
rer’s clefts), play a key role in the asexual lifecycle. How 
might all these membrane proteins fit together in the 
parasite’s ‘sensing apparatus’? Many studies have reported 
that heat shock proteins HSP70 and HSP90 regulate 
a number of signalling cascades to maintain cellular 
Fig. 8 The 32–35 kDa region (covering the PfAB4 proteins) of ItG pRBC from 1D SDS-PAGE were excised and in-gel digested with trypsin. The phos-
phopeptides were enriched using Pierce Magnetic Titanium Dioxide kit and subjected to Oribitrap mass spectroscopy. This enabled the identifica-
tion of triple phosphorylation sites in the PfAB4 protein at serine 87, serine 91 and serine 92, which is the PfPCNA1 peptide: LCGANEsVVIssK
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homeostasis several species [58, 59]. Recent studies have 
revealed that HSP70 and HSP90 proteins regulate the 
function of the IKK complex, which is the major activa-
tor of the NF-κB complex [60]. It has been shown that the 
histidine kinase auto-phosphorylates in the presence of 
an intra-or extra-cellular environment stimulus or stress, 
which could be one of the triggers. HSP90 plays an impor-
tant role in TNF-mediated NF-kB activation by modu-
lating the stability and solubility of receptor interacting 
protein (RIP) [61]. In this study, antibody AB4 recognized 
a 90  kDa protein consistent with being HSP90, which 
was supported by Western blot with an anti-HSP90 anti-
body (Additional file  4). This was also confirmed by co-
immunoprecipitation followed by mass spectrum. HSP90 
inhibitor Gambogic acid not only inhibited the expression 
of this 90  kDa protein, but also abrogated the effects of 
TNF on PfAB4. This suggests that PfPCNA1 may be one 
of the HSP90 client proteins, which may explain its iden-
tification by AB4 immuno-precipitation and co-migration 
in the gel electrophoresis. Such an association has been 
reported previously in several cancer cell lines [62]. The 
proteins in the insoluble fraction are probably cell mem-
brane components or have high affinity binding to the 
cytoskeleton, and these potentially could be the ‘percep-
tion proteins’ of pRBC. Although data are incomplete 
they suggest, for the first time, a link between PCNA1 and 
HSP90 in a parasite sensing system.
An attempt was made to investigate the outcome of 
the TNF regulatory mechanism of P. falciparum parasite 
strains by analysing transcriptomes of the 3D7 and Dd2 
strains (representing high and low PfAB4 phenotypes) 
with and without TNF treatment by RNAseq analysis. A 
remarkable conservation of the normal transcriptional 
programme between these strains has previously been 
observed [63]. The results showed no transcriptional dif-
ferences associated with TNF treatment. This suggests that 
post-transcriptional mechanisms may drive the signalling 
processes and changes to the global transcription pattern 
in the parasite may only occur in subsequent cycles, which 
was not investigated. Indeed it is tempting to speculate 
that changes in var gene expression might be linked to 
the TNF status in the host to align with altered host adhe-
sion profiles, and might not be detected until one or more 
cycles after exposure of pRBC to this cytokine.
The cell cycle checkpoints are signal transduction path-
ways that respond to damaged DNA by inhibiting cell 
cycle progression [64]. The post-translational modifica-
tions of PCNA are considered to be the most relevant dur-
ing the S phase cell cycle checkpoint (surveillance system) 
[65]. PCNA interacts with several eukaryotic cell cycle 
proteins, binds to cyclin-CDK complexes [66] and CDK 
inhibitor p21 [67, 68]. PCNA forms complexes with criti-
cal checkpoint proteins, transducing both positive and 
negative signals [69]. It is possible that cell cycle check-
points may serve as switch points for choosing between 
cell proliferation and apoptosis, or even have a broader 
role in parasite replication. The ability to sense the exter-
nal environment and, for example, move a proportion of 
the population into a quiescent phase could be beneficial 
to the parasite in avoiding killing by drugs and a protein 
such as PfPCNA1 could play a significant role in this.
Conclusion
This study reported a novel sensing system and some 
potential regulation mechanisms by which parasites 
respond to external stimuli including inflammatory 
cytokines, such as TNF. The sensing and regulating sys-
tem/rapid responding system in P. falciparum described 
here might be an equivalent of the two-component 
regulatory system of bacterial signal transduction. 
HSP90 could be a component of a membrane-bound 
histidine kinase that receives the input stimuli from as 
yet uncharacterized external receptors, and reversible 
phosphorylated PfPCNA1 could be a response regula-
tor that effects an appropriate change in cellular physi-
ology from this event. This sensing system might also 
be shared with cell cycle checkpoints, the stimuli which 
triggered PCNA1 dephosphorylation/degradation 
may also be implicated in DNA replication stress and 
damage. Further work is needed to identify the sensor 
proteins necessary for interacting with specific exter-
nal signals and the outcomes for the parasite from this 
system.
Additional files
Additional file 1. The proteins from normal RBC and ItG pRBC were 
extracted and separated by SDS-PAG-electrophoresis. The signalling 
proteins for ten pathways were measured by Western blot. The red arrow 
indicates the only positive identification of PfAB4. The experiment has 
been performed independently three times to confirm the results.
Additional file 2. The osmolality of culture reagents used in the labora-
tory were measured using a pocket OSMOCHECK (PAL-OSMO) (VITECH 
Scientific Ltd, UK) (A). ItG-pRBC growing in blue (serum containing) 
medium were placed into Plasmion mix (1:1.5:2.5) for 20 min. Then these 
pRBCs were centrifuged to change to either blue or yellow (serum-free) 
medium for 5, 15 and 60 min. The expression of PfAB4 was measured by 
Western blot (B). The results indicated that transfer from lower osmolality 
solution to a higher osmolality (blue to 1:1.5:2.5) had no effect on expres-
sion of PfAB4, but from higher osmolality solution to a lower osmolality 
solution (1:1.5:2.5 to blue or yellow) increased the expression of PfAB4.
Additional file 3. The proteins from Dd2 and ItG pRBC were extracted 
at the time points of IDC and separated by SDS-PAG-electrophoresis, 
followed by Western blot using AB4 antibodies. The results show that the 
expression of PfAB4 in Dd2 was low (A) and the protein was localized in 
the cytosol (B).
Additional file 4. ItG-pRBC were treated with 10 ng/ml TNF for 60, 30, 
15 and 5 min and the cellular proteins were extracted and separated by 
SDS-PAGE, followed by Western blot probed with anti-HSP90 and AB4 
antibodies. The 90kDa protein recognized by the two antibodies showed 
similar expression patterns.
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